Skip to main content

Table 1 Abeta accumulation was not modified in the lithium treated PS1xAPP mice

From: In vivo modification of Abeta plaque toxicity as a novel neuroprotective lithium-mediated therapy for Alzheimer’s disease pathology

  

Control

Lithium

Soluble Abeta42

ELISA

27.57 ± 10.74

30.14 ± 6.47

(pg/ml)

 

n = 7

n = 7

Total Abeta

Western blots

1.0 ± 0.26

0.98 ± 0.60

(relative units)

6E10

n = 18

n = 25

Abeta load

Immunohistochemistry

6.83 ± 1.99

4.40 ± 1.81

(% of area)

6E10

n = 5

n = 5

Abeta42 load

Immunohistochemistry

5.09 ± 2.31

3.65 ± 1.03

(% of area)

Abeta42

n = 5

n = 5

  1. Data are mean ± S.D.